Assurance methods for designing a clinical trial with a delayed treatment effect
Statistics in Medicine · 2024
DOI: 10.1002/sim.10136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, 2024. Verfasst von James A Salsbury und 3 weiteren Autor:innen. Beteiligte Einrichtung: The School of Mathematics and Statistics, The University of Sheffield, Sheffield, UK. Hauptthemen laut MEDLINE: Bayes Theorem, Research Design. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council.
Abstract (Originalsprache)
An assurance calculation is a Bayesian alternative to a power calculation. One may be performed to aid the planning of a clinical trial, specifically setting the sample size or to support decisions about whether or not to perform a study. Immuno‐oncology is a rapidly evolving area in the development of anticancer drugs. A common phenomenon that arises in trials of such drugs is one of delayed treatment effects, that is, there is a delay in the separation of the survival curves. To calculate assurance for a trial in which a delayed treatment effect is likely to be present, uncertainty about key parameters needs to be considered. If uncertainty is not considered, the number of patients recruited may not be enough to ensure we have adequate statistical power to detect a clinically relevant treatment effect and the risk of an unsuccessful trial is increased. We present a new elicitation technique for when a delayed treatment effect is likely and show how to compute assurance using these elicited prior distributions. We provide an example to illustrate how this can be used in practice and develop open‐source software to implement our methods. Our methodology has the potential to improve the success rate and efficiency of Phase III trials in immuno‐oncology and for other treatments where a delayed treatment effect is expected to occur.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The School of Mathematics and Statistics, The University of Sheffield, Sheffield, UK.
- The School of Health and Related Research, The University of Sheffield, Sheffield, UK.
- Advanced Methodology and Data Science, Novartis Pharma AG, Basel, Switzerland.
ORCID-Profile: James A Salsbury, Steven A Julious
Förderung
- Engineering and Physical Sciences Research Council
Zitieren
APA
Salsbury, J. A., Oakley, J. E., Julious, S. A., & Hampson, L. V. (2024). Assurance methods for designing a clinical trial with a delayed treatment effect. Statistics in Medicine. https://doi.org/10.1002/sim.10136
Vancouver
Salsbury JA, Oakley JE, Julious SA, Hampson LV. Assurance methods for designing a clinical trial with a delayed treatment effect. Statistics in Medicine. 2024. doi:10.1002/sim.10136
BibTeX
@article{Salsbury2024,
author = {Salsbury, James A and Oakley, Jeremy E and Julious, Steven A and Hampson, Lisa V},
title = {Assurance methods for designing a clinical trial with a delayed treatment effect},
journal = {Statistics in Medicine},
year = {2024},
doi = {10.1002/sim.10136}
}
EUVIMED